News

Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw ...
Survival outcomes favored the higher dose: more than 93% of patients in the 70 Gy group were alive one year after treatment, ...
Drinking beetroot juice in the morning without food may improve the absorption of nitrates that can help lower blood pressure ...
The guideline recommendations advise universal use of hydroxychloroquine, minimizing steroids, and earlier introduction of ...
6, 7, 10, 12 Optimizing the dose of ATG to minimize infectious complications and retain the suppressive effect on GvHD may enhance its value as a second-line treatment for acute GvHD ...
A new study shows higher doses of radiation given over fewer sessions for breast cancer was as effective as being given lower ...
Verve Therapeutics, in an official release, noted that the initial results of the VERVE-102 clinical trial demonstrated no ...
The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...
Sanofi's $470M Vigil Neuroscience, Inc. acquisition highlights VG-3927's potential in Alzheimer's. Click here to find out why ...
The FDA has approved Brekiya (dihydroergotamine mesylate) injection for the acute treatment of migraine with or without aura and the acute treatment of cluster headaches in adults.
A phase 1b study of HC-7366 plus Welireg for advanced clear cell renal cell carcinoma has completed the dose escalation ...
The trial is designed to assess the therapy's efficacy when administered subcutaneously in single ascending doses.